Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 16, 2024; 12(2): 346-353
Published online Jan 16, 2024. doi: 10.12998/wjcc.v12.i2.346
Use of MLC901 in cerebral venous sinus thrombosis: Three case reports
Anita Ante Arsovska, Narayanaswamy Venketasubramanian
Anita Ante Arsovska, Department of Urgent Neurology, University Clinic of Neurology, University Ss. Cyril and Methodius-Faculty of Medicine, Skopje 1000, North Macedonia
Narayanaswamy Venketasubramanian, Department of Neurology, Raffles Hospital, Singapore 188770, Singapore
Author contributions: Arsovska A contributed to the conceptualization, supervision, manuscript writing, editing, and data collection; Venketasubramanian N contributed to the conceptualization, manuscript writing, and editing; All authors have read and approved the final manuscript.
Informed consent statement: The Ethics Committee waived the requirement to obtain written informed consent from the patients for the anonymized reporting of their case details.
Conflict-of-interest statement: All the authors have no conflicts of interest to declare.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Anita Ante Arsovska, MD, PhD, Professor, Department of Urgent Neurology, University Clinic of Neurology, University Ss. Cyril and Methodius-Faculty of Medicine, Bul. Majka Tereza 17, Skopje 1000, North Macedonia. anita70mk@yahoo.com
Received: August 17, 2023
Peer-review started: August 17, 2023
First decision: September 5, 2023
Revised: October 17, 2023
Accepted: December 27, 2023
Article in press: December 27, 2023
Published online: January 16, 2024
Processing time: 147 Days and 1.7 Hours
Core Tip

Core Tip: The purpose of this study was to assess the potential role of NeuroAiD II™ (MLC901; Moleac Pte, Ltd, Singapore) in post-stroke recovery in a series of patients diagnosed with cerebral venous sinus thrombosis and treated with anticoagulation therapy.